Phenotyping of isolated mesh associated pain secondary to continence mesh device insertion - Report - MDSpire

Phenotyping of isolated mesh associated pain secondary to continence mesh device insertion

  • By

  • Hawra Badri

  • Karen Ward

  • Richard Edmondson

  • Fiona Reid

  • June 17, 2026

  • 0 min

Share

Clinical Report: Characterization of Phenotypes in Isolated Mesh-Related Pain

Overview

This study characterizes the pain phenotypes in women experiencing Isolated Mesh Associated Pain Syndrome (I-MAPS) following continence device insertion. It identifies a predominance of neuropathic pain and highlights the significant impact on quality of life and mental well-being.

Background

Isolated Mesh Associated Pain Syndrome (I-MAPS) is the most common complication following the insertion of continence mesh devices, with chronic pain being a significant concern for affected women. Understanding the pain mechanisms and phenotypes associated with I-MAPS is crucial for developing effective management strategies. The study aims to elucidate these aspects to improve patient care and outcomes.

Data Highlights

ParameterValue
Total Patients280
Pre-existing Pain Conditions52% (146/280)
Neuropathic Pain (PDQ)55% (78/142)
Nociceptive Pain22% (31/142)
Mixed Origin Pain23% (33/142)
Mean PDQ Score (TOT)20
Mean PDQ Score (Retropubic)17
Quality of Life Score53/100
Mental Well-being Score28/100

Key Findings

  • I-MAPS is primarily characterized by neuropathic pain, with 55% of patients exhibiting this phenotype.
  • 52% of patients reported pre-existing pain conditions prior to mesh insertion.
  • Trans-obturator devices were associated with a higher mean PDQ score compared to retropubic devices (20 vs. 17).
  • Patients reported moderate impacts on daily activities and significant levels of anxiety and depression.
  • Quality of life and mental well-being scores were notably low, indicating a multidimensional burden of chronic pain.

Clinical Implications

Clinicians should consider the neuropathic nature of pain in patients with I-MAPS when developing treatment plans. A multidisciplinary approach may be beneficial in addressing the complex needs of these patients, particularly in managing pain and improving quality of life.

Conclusion

The characterization of pain phenotypes in I-MAPS reveals a significant prevalence of neuropathic pain and highlights the need for targeted management strategies to address the associated functional and psychological burdens.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Hernia, Forecasting Outcomes of Revision Surgery for Mesh-Associated Issues Following Inguinal Hernia and Pelvic Organ Prolapse Procedures
  3. Hernia, Proactive iliohypogastric nerve resection to avert chronic pain following inguinal hernia surgery
  4. Techniques in Coloproctology, Clinical Features Associated with Different Phenotypes of Fecal Incontinence
  5. EAU Guidelines on Non-neurogenic Female LUTS 2025
  6. 5-Year Longitudinal Follow-up after Retropubic and Transobturator Midurethral Slings - PMC
  7. ICS-EUS 2025 Abstract #516 Phenotyping of Mesh Associated Pain Syndrome (MAPS) in continence mesh devices
  8. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-neurogenic-Female-LUTS-2025.pdf
  9. 5-Year Longitudinal Follow-up after Retropubic and Transobturator Midurethral Slings - PMC
  10. ICS-EUS 2025 Abstract #516 Phenotyping of Mesh Associated Pain Syndrome (MAPS) in continence mesh devices

Original Source(s)

Related Content